The Company announces that Susan O’Connor has completed her term as interim CFO, and Paul Murphy, Head of Group Reporting, has been promoted to the role of Interim CFO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech awarded order for 9M TrinScreen HIV tests
- Trinity Biotech Accelerates Global Rollout of High-Capacity HbA1c Column System After New Regulatory Clearances
- Trinity Biotech expands global rollout of high-capacity column system
- Trinity Biotech Secures WHO Approval for Offshore Manufacturing of HIV Test
- Trinity Biotech Collaborates to Enhance Prostate Cancer Test
